Truvestments Capital LLC Amphastar Pharmaceuticals, Inc. Transaction History
Truvestments Capital LLC
- $519 Million
- Q3 2025
A detailed history of Truvestments Capital LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Truvestments Capital LLC holds 154 shares of AMPH stock, worth $4,013. This represents 0.0% of its overall portfolio holdings.
Number of Shares
154
Previous 317
51.42%
Holding current value
$4,013
Previous $7,000
42.86%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AMPH
# of Institutions
263Shares Held
33.5MCall Options Held
73.4KPut Options Held
12.6K-
Black Rock Inc. New York, NY5.94MShares$155 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.63MShares$68.6 Million0.0% of portfolio
-
Td Asset Management Inc1.93MShares$50.3 Million0.05% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.76MShares$45.8 Million0.01% of portfolio
-
State Street Corp Boston, MA1.5MShares$39.1 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.28B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...